Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
PaperCitations, authors & open-access status
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 34 citations, 2024 year and closed oa status.
34
Citations
2024
Year
closed
OA Status